Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Askina Pad dressing 20cm x 10cm
20030100398
|
Askina Pad dressing 20cm x 10cm | Wound Management & Other Dressings | Dressings | No data available |
|
Askina Pad dressing 5cm x 5cm
20030100396
|
Askina Pad dressing 5cm x 5cm | Wound Management & Other Dressings | Dressings | No data available |
|
Askina SilNet dressing 20cm x 30cm
20030900138
|
Askina SilNet dressing 20cm x 30cm | Wound Management & Other Dressings | Dressings | No data available |
|
Askina SilNet dressing 7.5cm x 10cm
20030900136
|
Askina SilNet dressing 7.5cm x 10cm | Wound Management & Other Dressings | Dressings | No data available |
|
Askit oral powder sachets
0407010W0BBABA0
|
Askit | Aspirin combined preparations | Central Nervous System | No data available |
|
Asmabec 100 Clickhaler
0302000C0BIAEBJ
|
Asmabec | Beclometasone dipropionate | Respiratory System | No data available |
|
Asmabec 250 Clickhaler
0302000C0BIAFBK
|
Asmabec | Beclometasone dipropionate | Respiratory System | No data available |
|
Asmabec 50 Clickhaler
0302000C0BIADBI
|
Asmabec | Beclometasone dipropionate | Respiratory System | No data available |
|
Asmasal 95micrograms/dose Clickhaler
0301011R0BJABAF
|
Asmasal | Salbutamol | Respiratory System | No data available |
|
Asmavent 100micrograms/dose inhaler CFC free
0301011R0BYAAAP
|
Asmavent | Salbutamol | Respiratory System | No data available |
|
Asparaginase 10,000unit inj vials
0801050BUAAABAB
|
Asparaginase | Asparaginase | Malignant Disease and Immunosuppression | No data available |
|
Asparaginase 5,000unit inj vials
0801050BUAAAAAA
|
Asparaginase | Asparaginase | Malignant Disease and Immunosuppression | No data available |
|
Aspav dispersible tablets
0407010A0BBAAAB
|
Aspav | Aspirin and papaveretum | Central Nervous System | No data available |
|
Aspirin 100mg/5ml oral liquid
0209000A0AAA5A5
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 150mg / Isosorbide mononitrate 60mg MR tab
0206010W0AAABAB
|
Isosorbide mononitrate/aspirin | Isosorbide mononitrate with aspirin | Cardiovascular System | No data available |
|
Aspirin 15mg/5ml oral liquid
0209000A0AABHBH
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 225mg/5ml oral liquid
0209000A0AABJBJ
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 25mg capsules
0209000A0AAATAT
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 25mg/5ml oral liquid
0209000A0AABABA
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 300mg / Paracetamol 200mg dispersible tab sugar free
0407010S0AAACAC
|
Aspirin/paracetamol | Aspirin and paracetamol | Central Nervous System | No data available |
|
Aspirin 300mg effervescent tablets sugar free
0407010B0AACCCC
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 300mg modified-release tablets
0407010B0AACGCG
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 300mg orodispersible tablets sugar free
0407010B0AAANAN
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 300mg/5ml oral liquid
0407010B0AAABAB
|
Aspirin (Analgesic) | Aspirin | Central Nervous System | No data available |
|
Aspirin 30mg/5ml oral liquid
0209000A0AABFBF
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.